Skip to main content

Table 3 Grade 3–4 acute toxicity profiles during induction chemotherapy and radiotherapy

From: Anti-EGFR targeted therapy delivered before versus during radiotherapy in locoregionally advanced nasopharyngeal carcinoma: a big-data, intelligence platform-based analysis

Grade 3–4 toxicity

Investigational arm

Control arm

P valuea

 

(N = 149, %)

(N = 147, %)

 

Any

87 (58.4%)

86 (58.5%)

0.984

Induction phase

 Leucopenia

36 (24.2)

27 (18.4)

0.223

 Neutropenia

61 (40.9)

45 (30.6)

0.064

 Anaemia

2 (1.3)

2 (1.4)

0.989

 Thrombocytopenia

5 (3.4)

1 (0.7)

0.102

 Liver function

3 (2.0)

2 (1.4)

0.663

 Renal function

0 (0)

0 (0)

1.000

 Skin reaction

23 (15.4)

3 (2.0)

< 0.001

 Mucositis

15 (10.1)

5 (3.4)

0.022

 Nausea

3 (2.0)

2 (1.4)

0.663

 Vomiting

8 (5.4)

12 (8.2)

0.338

 Diarrhoea

3 (2.0)

1 (0.7)

0.321

Concurrent phase

 Leucopenia

31 (20.8)

40 (27.2)

0.197

 Neutropenia

19 (12.8)

24 (16.3)

0.383

 Anaemia

11 (7.4)

15 (10.2)

0.391

 Thrombocytopenia

13 (8.7)

8 (5.4)

0.271

 Liver function

3 (2.0)

5 (3.4)

0.462

 Renal function

0 (0)

2 (1.4)

0.246

 Skin reaction

8 (5.4)

38 (25.9)

< 0.001

 Mucositis

37 (24.8)

54 (36.7)

0.026

 Nausea

14 (9.4)

18 (12.2)

0.430

 Vomiting

20 (13.4)

22 (15.0)

0.704

 Diarrhoea

2 (1.3)

5 (3.4)

0.244

  1. aP-values were calculated by Chi-square test or Fisher exact test